Tuesday, September 3, 2013

Belgium's MDxHealth signs U.S. deal for cancer test

BRUSSELS (Reuters) - Belgian biotech firm MDxHealth has signed a deal with U.S. healthcare network Stratose, which will give its prostate cancer testing product access to one of the largest networks in the United States.






No comments:

Post a Comment

Subscribe Now: Feed Icon